GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.96+4.67 (+9.88%)
Close on Nov 18, 2026Market cap $1.55BP/E –Yield –
GeneDx price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
GeneDx's price to book ratio was 6.7× on Nov 10, 2026, against 16.5× a year earlier. Over the last 5 years it ranged from 0.2× to 16.5×, with a median of 4.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 6.7× | −6.2 |
| 2025 | Dec 31, 2025 | 12.9× | +2.5 |
| 2024 | Dec 31, 2024 | 10.3× | +10.0 |
| 2023 | Dec 29, 2023 | 0.3× | +0.1 |
| 2022 | Dec 30, 2022 | 0.2× | – |
See a number that looks wrong?